Stockreport

Ocugen Provides Business Update and Third Quarter 2019 Financial Highlights

Ocugen, Inc.  (OCGN) 
PDF MALVERN, Pa., Nov. 08, 2019 (GLOBE NEWSWIRE) -- Ocugen, Inc., (NASDAQ: OCGN), a clinical stage biopharmaceutical company focused on discovering, developing and commerc [Read more]